학술논문
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Document Type
Article
Author
Mackenzie, I.S.; Pigazzani, F.; Rogers, A.; Struthers, A.D.; Begg, A.G.; Duce, S.L.; Barr, R.J.; Rooke, E.D.; MacDonald, T.M.; Hawkey, C.J.; Dumbleton, J.S.; Avery, A.J.; Taggar, J.S.; Ford, I.; Greenlaw, N.; Wei, L.; Walker, A.; Townend, J.N.; Ritchie, L.D.; Ahmed, H.; Arthur, P.; Aziz, J.; Barnes, L.; Boyle, S.; Brighton, T.; Brown, M.; Caulfield, M.; Dawson, J.; Denvir, M.; Doney, A.S.; Doshi, S.; Dryburgh, M.; Eddleston, M.; Finlayson, J.; Fuat, A.; Furnace, J.; Grieve, J.K.; Guthrie, G.; Ham, S.; Isaard, E.; Jennings, C.; Johnson, R.; Kerr, C.; Khan, S.; Krishnan, K.; Long, S.; Mackintosh, A.; Macleod, M.J.; McCormack, T.; McEleny, P.; Morar, M.; Nadir, A.; Newby, D.; Petrie, C.; Preiss, D.; Ralston, S.; Randall, M.; Routledge, H.; Shakir, S.; Sharma, R.; Shepherd, B.; Sims, D.; Snedden, G.; Trevelyan, J.; Weir, C.; Weir, R.; Wetherall, K.; Wilson, R.; Wilson, A.; Zutis, K.
Source
In: The Lancet . (The Lancet, 8 October 2022, 400(10359):1195-1205)
Subject
Language
English
ISSN
1474547X
01406736
01406736